{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:08:48Z","timestamp":1788988128717,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012236","name":"Beijing Institute of Technology Research Fund Program for Young Scholars","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neurot.2026.e00963","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:51:46Z","timestamp":1783666306000},"page":"e00963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of dual antiplatelet treatment up to 72 hours after mild ischemic stroke or transient ischemic attack in patients with established cardiovascular disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Zhang","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Claiborne","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Amarenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Bath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e00963_bib1","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","article-title":"Dual antiplatelet treatment up to 72 hours after ischemic stroke","volume":"389","author":"Gao","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurot.2026.e00963_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000544170","article-title":"Comorbidity patterns in patients with first-ever acute ischemic stroke and their associations with functional outcomes","volume":"60","author":"Huang","year":"2026","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurot.2026.e00963_bib3","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2026.e00963_bib4","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2026.e00963_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejvs.2003.12.025","article-title":"Aspirin resistance in cardiovascular disease: a review","volume":"27","author":"Wong","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.neurot.2026.e00963_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1160\/TH06-08-0420","article-title":"Thienopyridines in cardiovascular disease: focus on clopidogrel resistance","volume":"97","author":"Siller-Matula","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.neurot.2026.e00963_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/eurheartj\/ehi684","article-title":"Aspirin and clopidogrel resistance: an emerging clinical entity","volume":"27","author":"Wang","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.neurot.2026.e00963_bib8","first-page":"463","article-title":"Dual antiplatelet therapy for patients with cardiovascular disease","volume":"100","author":"McLaughlin","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.neurot.2026.e00963_bib9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","article-title":"One-year risk of stroke after transient ischemic attack or minor stroke","volume":"374","author":"Amarenco","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurot.2026.e00963_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/svn-2022-002084","volume":"8","author":"Gao","year":"2023","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.neurot.2026.e00963_bib11","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1001\/jama.2020.23068","article-title":"Association between depressive symptoms and incident cardiovascular diseases","volume":"324","author":"Harshfield","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.neurot.2026.e00963_bib12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamacardio.2025.0109","article-title":"Food insecurity and incident cardiovascular disease among black and white US individuals, 2000-2020","volume":"10","author":"Jia","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.neurot.2026.e00963_bib13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jamacardio.2017.1460","article-title":"Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction : a secondary analysis of the TRANSLATE-ACS study","volume":"2","author":"Guimar\u00e3es","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.neurot.2026.e00963_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/eurjpc\/zwae379","article-title":"Albiglutide and atrial fibrillation in patients with type 2 diabetes and established cardiovascular disease - insights from the Harmony Outcomes trial","volume":"33","author":"Krychtiuk","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.neurot.2026.e00963_bib15","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1111\/dom.16271","article-title":"Estimating healthcare resource utilisation and cardiovascular events in people with high body mass index and established cardiovascular disease","volume":"27","author":"Pearson-Stuttard","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.neurot.2026.e00963_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1308173","article-title":"Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins","volume":"10","author":"Vijayaraghavan","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.neurot.2026.e00963_bib17","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.neurot.2026.e00963_bib18","first-page":"CD005158","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events","volume":"12","author":"Squizzato","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurot.2026.e00963_bib19","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurot.2026.e00963_bib20","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/ATVBAHA.124.320902","article-title":"Thrombin generation is associated with extracellular vesicle and leukocyte lipid membranes in atherosclerotic cardiovascular disease","volume":"44","author":"Protty","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.neurot.2026.e00963_bib21","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/ATVBAHA.120.315754","article-title":"Thrombus structural composition in cardiovascular disease","volume":"41","author":"Alkarithi","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.neurot.2026.e00963_bib22","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/HYPERTENSIONAHA.121.16975","article-title":"Role of microparticles in cardiovascular disease: implications for endothelial dysfunction, thrombosis, and inflammation","volume":"77","author":"Lugo-Gavidia","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.neurot.2026.e00963_bib23","first-page":"575","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.neurot.2026.e00963_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/STROKEAHA.124.049246","article-title":"Dual antiplatelet treatment up to 72 hours after ischemic stroke stratified by risk profile: a post hoc analysis","volume":"56","author":"Zhang","year":"2025","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2026.e00963_bib25","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.2011.1703","article-title":"Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease","volume":"306","author":"Mega","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.neurot.2026.e00963_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2014.11.037","article-title":"Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel","volume":"747","author":"Qiu","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2026.e00963_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MCA.0000000000000092","article-title":"CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention","volume":"25","author":"Liu","year":"2014","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.neurot.2026.e00963_bib28","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.12659\/MSM.892475","article-title":"Analysis of the CYP2C19 genetic polymorphism in Han and Uyghur patients with cardiovascular and cerebrovascular diseases in the Kashi area of Xinjiang","volume":"20","author":"Li","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.neurot.2026.e00963_bib29","first-page":"166","volume":"vol. 20","author":"Ma","year":"2011"},{"key":"10.1016\/j.neurot.2026.e00963_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2217\/14622416.9.6.691","article-title":"Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China","volume":"9","author":"Chen","year":"2008","journal-title":"Pharmacogenomics"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:34:19Z","timestamp":1788986059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1878747926001339"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00963","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of dual antiplatelet treatment up to 72 hours after mild ischemic stroke or transient ischemic attack in patients with established cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00963"}}